Influenza, General

Influenza, General

Latest Posts

  • Cidrap EDU, Influenza, General, RSS
Report: Influenza A and B clinically different, and type B patients less likely to receive antiviral​
  • Cidrap EDU, Influenza, General, RSS
US flu season shows signs of peak​
  • Cidrap EDU, Influenza, General, RSS
CDC: 13% of kids who died from flu this year had brain damage​
  • Cidrap EDU, Influenza, General, RSS
US flu still high, COVID low but elevated in some areas, RSV declining, CDC says​
  • Cidrap EDU, Influenza, General, RSS
New calculation method estimates 380,000 US flu hospitalizations in 2022-23​
  • Cidrap EDU, Influenza, General, RSS
US flu reaches high severity status as deaths outpace COVID​
  • Cidrap EDU, Influenza, General, RSS
US sees no let-up in rising flu activity​
  • Cidrap EDU, Influenza, General, RSS
Studies show how RSV, flu compare, interact in a season​
  • Cidrap EDU, Influenza, General, RSS
Tamiflu cuts risk of death in older adults, study suggests​
  • Cidrap EDU, Influenza, General, RSS
Meta-analysis estimates 14% global COVID-flu coinfection rate​
Load More
  • Cidrap EDU, Influenza, General, RSS
Quick takes: More avian flu in Indiana, cases of New World screwworm in Mexico, rising US flu activity​
  • Cidrap EDU, Influenza, General, RSS
US measles outbreak tops 1,800 cases as respiratory illness surveillance returns​
  • Cidrap EDU, Influenza, General, RSS
US flu activity on the rise​
  • Cidrap EDU, Influenza, General, RSS
Quick takes: Egg Salmonella outbreak called over, new Marburg cases in Ethiopia, intense flu in Japan​
  • Cidrap EDU, Influenza, General, RSS
Quick takes: Avian flu death in Cambodia, return of US FluView​
  • Cidrap EDU, Influenza, General, RSS
Some common viruses may steeply raise risk of cardiovascular disease​
  • Cidrap EDU, Influenza, General, RSS
Antiviral prescribing for kids at risk of severe flu declined during COVID, study finds​
  • Cidrap EDU, Influenza, General, RSS
US COVID declining after reaching peak​
  • Cidrap EDU, Influenza, General, RSS
US COVID levels may be peaking, CDC data show​
  • Cidrap EDU, Influenza, General, RSS
Osivax receives $19.5 million BARDA support for universal flu vaccine candidate​